ARCHIVES

Phase III Cyramza Trial Meets OS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Shift Of $6.5 Million From Contracts to Pay Core, P01s At Recommended Levels, Increase R01 Payline

June 27, 1980

Professional societies: ACCC honors Clinton For Cancer Drug Initiatives, Insurance Bill

September 27, 1996

Neural Stem Cells Track, Treat, Brain Tumors In Mice

November 29, 2002

Spiegelman Selected For BMS Award; Einstein Cancer Center Wins Grant.

July 4, 2003

M. D. Anderson Buys Record System For In-Patient Services From Atlanta Firm.

May 4, 2001

NCI Support Crucial for Israel cancer Studies; Weizmann Top Recipient

June 17, 1977